Cargando…
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer
BACKGROUND: TBX3 is a T-box transcription factor repressor that is elevated in metastatic breast cancer and is believed to promote malignancy of tumor cells, possibly by promoting cell survival and epithelial-mesenchymal transition. METHODS: The relative expression of TBX3 was assessed in the 21T ce...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994202/ https://www.ncbi.nlm.nih.gov/pubmed/27553211 http://dx.doi.org/10.1186/s12885-016-2697-z |
_version_ | 1782449278792237056 |
---|---|
author | Krstic, Milica Macmillan, Connor D. Leong, Hon S. Clifford, Allen G. Souter, Lesley H. Dales, David W. Postenka, Carl O. Chambers, Ann F. Tuck, Alan B. |
author_facet | Krstic, Milica Macmillan, Connor D. Leong, Hon S. Clifford, Allen G. Souter, Lesley H. Dales, David W. Postenka, Carl O. Chambers, Ann F. Tuck, Alan B. |
author_sort | Krstic, Milica |
collection | PubMed |
description | BACKGROUND: TBX3 is a T-box transcription factor repressor that is elevated in metastatic breast cancer and is believed to promote malignancy of tumor cells, possibly by promoting cell survival and epithelial-mesenchymal transition. METHODS: The relative expression of TBX3 was assessed in the 21T cell lines which were derived from an individual patient and represent three distinct stages of breast cancer progression: 21PT, atypical ductal hyperplasia; 21NT, ductal carcinoma in situ; and 21MT-1, invasive mammary carcinoma. Two different isoforms of TBX3 (TBX3iso1 and TBX3iso2) were overexpressed to evaluate cell survival/colony forming ability, growth, and invasion in the ductal carcinoma in situ-like 21NT cell line using an in vitro Matrigel model of cancer progression. In addition, TBX3 expression was knocked down to evaluate the effects of downregulating TBX3 on the invasive mammary carcinoma-like 21MT-1 cell line. Finally, PCR array profiling was used to assess alterations in gene expression due to TBX3 overexpression in the 21NT cells. RESULTS: TBX3 is abundant in the invasive 21MT-1 cell line, while being minimally expressed in the non-invasive 21NT and 21PT cell lines. Overexpression of either TBX3iso1 or TBX3iso2 in 21NT cells resulted in increased cell survival/colony forming ability, growth vs. apoptosis and invasion in Matrigel. In contrast, short hairpin RNA-mediated knockdown of TBX3 in the 21MT-1 cells resulted in smaller colonies, with a more regular, less dispersed (less infiltrative) morphology. Array profiling of the 21NT TBX3 iso1 and iso2 transfectants showed that there are common alterations in expression of several genes involved in signal transduction, cell cycle control/cell survival, epithelial-mesenchymal transition and invasiveness. CONCLUSIONS: Overall, these results indicate that TBX3 (isoform 1 or 2) expression can promote progression in a model of early breast cancer by altering cell properties involved in cell survival/colony formation and invasiveness, as well as key regulatory and EMT/invasiveness-related gene expressions. |
format | Online Article Text |
id | pubmed-4994202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49942022016-08-24 The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer Krstic, Milica Macmillan, Connor D. Leong, Hon S. Clifford, Allen G. Souter, Lesley H. Dales, David W. Postenka, Carl O. Chambers, Ann F. Tuck, Alan B. BMC Cancer Research Article BACKGROUND: TBX3 is a T-box transcription factor repressor that is elevated in metastatic breast cancer and is believed to promote malignancy of tumor cells, possibly by promoting cell survival and epithelial-mesenchymal transition. METHODS: The relative expression of TBX3 was assessed in the 21T cell lines which were derived from an individual patient and represent three distinct stages of breast cancer progression: 21PT, atypical ductal hyperplasia; 21NT, ductal carcinoma in situ; and 21MT-1, invasive mammary carcinoma. Two different isoforms of TBX3 (TBX3iso1 and TBX3iso2) were overexpressed to evaluate cell survival/colony forming ability, growth, and invasion in the ductal carcinoma in situ-like 21NT cell line using an in vitro Matrigel model of cancer progression. In addition, TBX3 expression was knocked down to evaluate the effects of downregulating TBX3 on the invasive mammary carcinoma-like 21MT-1 cell line. Finally, PCR array profiling was used to assess alterations in gene expression due to TBX3 overexpression in the 21NT cells. RESULTS: TBX3 is abundant in the invasive 21MT-1 cell line, while being minimally expressed in the non-invasive 21NT and 21PT cell lines. Overexpression of either TBX3iso1 or TBX3iso2 in 21NT cells resulted in increased cell survival/colony forming ability, growth vs. apoptosis and invasion in Matrigel. In contrast, short hairpin RNA-mediated knockdown of TBX3 in the 21MT-1 cells resulted in smaller colonies, with a more regular, less dispersed (less infiltrative) morphology. Array profiling of the 21NT TBX3 iso1 and iso2 transfectants showed that there are common alterations in expression of several genes involved in signal transduction, cell cycle control/cell survival, epithelial-mesenchymal transition and invasiveness. CONCLUSIONS: Overall, these results indicate that TBX3 (isoform 1 or 2) expression can promote progression in a model of early breast cancer by altering cell properties involved in cell survival/colony formation and invasiveness, as well as key regulatory and EMT/invasiveness-related gene expressions. BioMed Central 2016-08-23 /pmc/articles/PMC4994202/ /pubmed/27553211 http://dx.doi.org/10.1186/s12885-016-2697-z Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Krstic, Milica Macmillan, Connor D. Leong, Hon S. Clifford, Allen G. Souter, Lesley H. Dales, David W. Postenka, Carl O. Chambers, Ann F. Tuck, Alan B. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title_full | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title_fullStr | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title_full_unstemmed | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title_short | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer |
title_sort | transcriptional regulator tbx3 promotes progression from non-invasive to invasive breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994202/ https://www.ncbi.nlm.nih.gov/pubmed/27553211 http://dx.doi.org/10.1186/s12885-016-2697-z |
work_keys_str_mv | AT krsticmilica thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT macmillanconnord thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT leonghons thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT cliffordalleng thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT souterlesleyh thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT dalesdavidw thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT postenkacarlo thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT chambersannf thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT tuckalanb thetranscriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT krsticmilica transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT macmillanconnord transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT leonghons transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT cliffordalleng transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT souterlesleyh transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT dalesdavidw transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT postenkacarlo transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT chambersannf transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer AT tuckalanb transcriptionalregulatortbx3promotesprogressionfromnoninvasivetoinvasivebreastcancer |